87258999
Dec 6, 2016
Regenerative cells for the treatment of scleroderma, hand complications associated with scleroderma, Raynaud's phenomenon, and ulceration of the fingers
PharmaceuticalsRegenerative cell therapy services for the hand for the treatment of scleroderma, hand complications associated with scleroderma, Raynaud's phenomenon, and ulceration of the fingers; Administration of regenerative cells relating to regenerative cell therapy services for the hand for the treatment of scleroderma, hand complications associated with scleroderma, Raynaud's phenomenon, and ulceration of the fingers; isolation of regenerative cells relating to regenerative cell therapy services for the hand for the treatment of scleroderma, hand complications associated with scleroderma, Raynaud's phenomenon, and ulceration of the fingers; all of the foregoing provided to medical professional and medical providers, medical research facilities, pharmaceutical professional providers, and healthcare professionals and providers
Medical, Beauty & Agricultural